Intensive Therapy for NPM1 Mutant AML Patients: Negative Impact of FLT3-ITDhighbut Not FLT3-ITDlow and FLT3-TKD and Role of Transplant in Patients over 60 Years of Age
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6285-6287
10.1182/blood-2022-170587